Pancreatic Cancer

Pancreatic cancer (PC) is one of the most lethal malignancies. The disease is almost always detected when at an advanced stage, hence biomarkers to facilitate earlier disease detection, when there are greater opportunities for effective treatment, are urgently sought.

SERVICES

Biomarkers

Traditional Detection Tools

  • CA19-9
  • Imaging Diagnosis
  • Abdominal Ultrasonography
  • Contrast-enhanced CT
  • MRI/MRCP
  • EUS W/O FNA
  • FDG-PET

 

Liquid biopsy and Bodily Fluids

Liquid Biopsy

cfDNA, CTCs and Exosomes.

Bodily Fluids

Fecal, Urinary and Salivary Biomarkers.

Novel Biomarkers

  • Genetic,
  • Epigenetic,
  • ncRNA,
  • Metabolomics,
  • Microbiome and
  • Proteomics.

Our approach

is a carefully validated, clinically realistic model for early diabetes mellitus screening and managing of the disease.

 

Our mathematical & computational tools

enable researchers and decision makers to make better informed decisions.